A Phase I Clinical Trial with a Novel gp41 HIV Vaccine (EN41-FPA2) in Healthy Female Volunteers: A Mucosal Prime and Intramuscular Boost Regimen - Cope,AV; Moog,C; Shattock,RJ; Chawda,MM; Czyzewska-Khan,J; Kat,P; Venables,S; Yan,C; Williams,M; Cobb,K; Singh,M; Oehlmann,W; et al. (AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014)